Alfuzosin Hydrochloride

CAS 81403-68-1 11 current records 8 historicalSmall Molecule

Who holds supplier records for Alfuzosin Hydrochloride? 11 organisations hold a current record for Alfuzosin Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), Canada (1), France (1), Germany (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Alfuzosin Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/alfuzosin-hydrochloride

Reading the evidence

  • 11 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    7 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (11)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Alfuzosin Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Alfuzosin Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (5)

Certificates of Suitability on the EDQM register for Alfuzosin Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2007-080 - Rev 04
Alfuzosin hydrochloride
Sept 2025—
UNICHEM LABORATORIES LIMITED MumbaiIN
CEP 2008-294 - Rev 01
Alfuzosin hydrochloride
Nov 2024—
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
CEP 2006-208 - Rev 06
Alfuzosin hydrochloride
Jan 2024—
EXCELLA GMBH & CO. KG FeuchtDE
R1-CEP 2007-126 - Rev 04
Alfuzosin hydrochloride
Mar 2022—
Farmak A.S. OlomoucCZ
R1-CEP 2003-098 - Rev 02
Alfuzosin hydrochloride
Aug 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Alfuzosin Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 8 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Alfuzosin Hydrochloride is an alpha-1 adrenergic receptor antagonist used primarily to treat benign prostatic hyperplasia (BPH). It works by relaxing muscles in the prostate and bladder neck, making it easier to urinate.

Chemical identity

IUPAC name
N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide;hydrochloride
Canonical SMILES
CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl
InChIKey
YTNKWDJILNVLGX-UHFFFAOYSA-N
Synonyms
Uroxatral API, alfuzosin hcl, sl 77 499-10, sl-77-499-10, sl-77499-10, uroxatral

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
alpha-Adrenergic Blocker
Mechanism of action
Adrenergic alpha-Antagonists

Therapeutic areas

Urology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Alfuzosin Hydrochloride?

11 organisations hold an active US FDA Type II Drug Master File or a CEP for Alfuzosin Hydrochloride: APITORIA PHARMA PRIVATE LTD (India), MSN Laboratories Private Limited (India), Unichem Laboratories Ltd. (India), ALIVUS LIFE SCIENCES LTD (India), Apotex Inc. (Canada), Hetero Drugs Limited (India), SANOFI CHIMIE (France) and Torrent Pharmaceuticals (India), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Alfuzosin Hydrochloride Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 20307), MSN Laboratories Private Limited (DMF 20867), Unichem Laboratories Ltd. (DMF 22638), ALIVUS LIFE SCIENCES LTD (DMF 19675), Apotex Inc. (DMF 20595), Hetero Drugs Limited (DMF 20577), SANOFI CHIMIE (DMF 20888) and Torrent Pharmaceuticals (DMF 23603) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Alfuzosin Hydrochloride records mean?

8 organisations have only inactive Type II DMFs for Alfuzosin Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Alfuzosin Hydrochloride have a European Certificate of Suitability?

Yes. 5 organisations hold a valid CEP for Alfuzosin Hydrochloride on the EDQM register, including APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), UNICHEM LABORATORIES LIMITED Mumbai (IN), MSN LABORATORIES PRIVATE LIMITED Rudraram Village (IN), EXCELLA GMBH & CO. KG Feucht (DE) and Farmak A.S. Olomouc (CZ). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Alfuzosin Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Alfuzosin Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.